To Be Discontinued Solution Pulmonary/Allergy
Tobramycin Solution · 3 active FDA presentation rows for this drug
Brand: TOBRAMYCIN
FDA lists Tobramycin Solution as To Be Discontinued (Teva Pharmaceuticals USA, Inc.).
No availability text on this FDA row.
Tobramycin Solution: To Be Discontinued
FDA availability text is not recorded on this row. 3 shortage presentations are tracked for this drug. Contact your pharmacist if you are affected.
Shortage Details
- Generic Name
- Tobramycin Solution
- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Dosage Form
- Solution
- Presentation
- Tobramycin, Solution, 300 mg/4 mL (NDC 0093-3750-28)
- Package NDC
- 0093-3750-28
Status & Timeline
- Status
- To Be Discontinued
- First Reported
- Jun 16, 2025
- Last Updated
- Jun 16, 2025
- Therapeutic Category
- Pulmonary/Allergy
Row fields from the FDA Drug Shortages database via openFDA.
Shortage Reason
Discontinuation of the manufacture of the drug
Full Drug Profile
tobramycin
Side effects, interactions, warnings & more
Nearby, Other Tobramycin Shortage Records
FDA reason on file: Discontinuation of the manufacture of the drug. General shortage guidance lives on the tracker hub.